MetabolicSemaglutide
GLP-1 receptor agonist analog studied in metabolic and glucose regulation research.
- Studied for glucose homeostasis
- Appetite regulation research
Metabolic
Tirzepatide
Dual GIP/GLP-1 receptor agonist for advanced metabolic research.
Purity
≥ 99% (HPLC)
Form
Lyophilized powder · 5 mg vial
Overview
Tirzepatide is a novel dual agonist targeting both GIP and GLP-1 receptors, studied for its compound effects on metabolic pathways.
Key Benefits
- Dual incretin pathway activation
- Studied for glycemic regulation
- Investigated for body composition changes
Research Applications
Obesity model researchType 2 diabetes studiesLipid metabolism
Educational Note
Combined GIP and GLP-1 activity offers a unique research profile that differs from selective GLP-1 analogs.
Related Products
MetabolicMetabolicMOTS-c
Mitochondrial-derived peptide studied in metabolic homeostasis research.
- Mitochondrial signaling research
- Insulin sensitivity studies
MetabolicAOD-9604
Modified fragment of hGH studied for lipolytic activity.
- Lipolysis research
- No IGF-1 elevation